Sukhatme Mayukh

President & CIO, DirectorRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Dec 31, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$28.9M
Net Open-Market Flow
-$28.9M
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2025Option exercise(M)2.4M$12.68$31.1M21.3M
Dec 31, 2025Other(J)1.4M$21.71$31.1M18.8M
Dec 31, 2025Sell(S)1.0M$21.71$22.1M20.3M
Dec 29, 2025Sell(S)312K$21.74$6.8M19.3M
Dec 29, 2025Option exercise(M)748K$12.68$9.5M19.6M
Dec 29, 2025Other(J)436K$21.74$9.5M18.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2025Option exercise(M)2.4M$096K
Dec 29, 2025Option exercise(M)748K$0556K

Transaction Codes

M
Option exercise / conversion
J
Other acquisition / disposition
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-047122) within minutes of acceptance. Every field above traces to the original document. Verify it directly: